Entero Healthcare Solutions Ltd
Entero Healthcare Solutions Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Organic growth estimated at 1.5x industry growth; sustainable growth expected beyond acquisitions. FY27 expected to be far better than FY26, driven by full-year impact of acquisitions made in FY26 and organic growth (Page 14).
From Entero Healthcare Solutions Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Organic growth estimated at 1.5x industry growth; sustainable growth expected beyond acquisitions.
- FY27 growth to be better than FY26 due to full-year impact of H2 FY26 acquisitions plus organic growth.
- Next year’s growth driven by acquisition impact and organic expansion, with no material slowdown anticipated.
- MedTech segment seen as a large growth opportunity with potential for faster growth due to pan-India exclusive distribution deals.
- Existing warehouse infrastructure and relationships with pharma companies provide leverage for further growth.
- Continuous expansion through acquiring companies that add unique geographies or product segments.
- Focus on wallet share increase in existing customers and cross-selling to newly acquired customers.
2 more points from Entero Healthcare Solutions Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Entero Healthcare Solutions Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The business is not capital intensive; most warehouses are leased.
- Capex primarily involves storage and cooling equipment with minimal fixed asset base.
- To set up one warehouse, capex requirement is approximately INR 30-40 lakhs.
- Recent acquisitions might require some capex but overall capex remains minimal relative to revenue.
- Next 2-3 quarters, focus will be on integrating recent acquisitions and improving margins rather than new acquisitions.
- Capex for FY27 is expected to be lower with more focus on cash generation and integration.
2 more points from Entero Healthcare Solutions Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Retailing
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Entero Healthcare Solutions Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Entero Healthcare Solutions Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Entero Healthcare Solutions Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.9K Cr, net profit ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Entero Healthcare Solutions Ltd's management said in earlier quarters
Others in Retailing this season
- Trent Ltd (Q3 FY26)
Q3 FY26 revenue from operations: ₹5,259 crore (Standalone), ₹5,345 crore (Consolidated) . Key concall takeaways from Trent Ltd's Q3 FY26 earnings call — and…
- Aditya Birla Lifestyle Brands Ltd (Q3 FY26)
Network expansion will drive an additional 5%-6% growth; plans include adding around 200 stores per year with at least 3-4 years of growth headroom. Key…
- Meesho Ltd (Q3 FY26)
56 crores and free cash flow to equity of Rs. Key concall takeaways from Meesho's Q3 FY26 earnings call — and how it ranks against sector peers.
- V2 Retail Ltd (Q3 FY26)
Planning to add 150 new stores in FY 2027, increasing total retail footprint by about 50%. Key concall takeaways from V2 Retail's Q3 FY26 earnings call — and…
Arthneeti Pro · Annual
Entero Healthcare Solutions Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Entero Healthcare Solutions Ltd Q3 FY26 results?
Organic growth estimated at 1.5x industry growth; sustainable growth expected beyond acquisitions. FY27 expected to be far better than FY26, driven by full-year impact of acquisitions made in FY26 and organic growth (Page 14).
What is Entero Healthcare Solutions Ltd share price analysis?
Entero Healthcare Solutions Ltd currently shows a neutral. The stock trades at a P/E of 46.3 with a market cap of ₹5,479 Cr. Investors should review the full earnings analysis for detailed insights.
Is Entero Healthcare Solutions Ltd planning capital expenditure?
The business is not capital intensive; most warehouses are leased.
Keep Entero Healthcare Solutions Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.